Status:
COMPLETED
Hymenoptera Venom Immunotherapy: Evaluation of Its Long-term Efficacy at the University Hospital of Angers (EFLOTITA2)
Lead Sponsor:
University Hospital, Angers
Conditions:
Anaphylaxis Caused by Hymenoptera Venom (Disorder)
Eligibility:
All Genders
Brief Summary
Allergy to Hymenoptera venom is one of the main causes of anaphylaxis in adults, and is less common in the paediatric population. It can be severe or even fatal. Despite the use of an emergency kit, ...
Detailed Description
Allergy to Hymenoptera venom is one of the main causes of anaphylaxis in adults, and is less common in the paediatric population. It can be severe or even fatal. Despite the use of an emergency kit, ...
Eligibility Criteria
Inclusion
- Allergy to hymenoptera venom.
- Treated with VIT at the university hospital of Angers.
- Ceased VIT between 2005 and 2019.
Exclusion
- Patient's opposition, or the Participant's legal guardian's, if minor, to participate to the study, and/or for his data to be used.
Key Trial Info
Start Date :
April 14 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 14 2024
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT05311644
Start Date
April 14 2022
End Date
March 14 2024
Last Update
July 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of Angers
Angers, Maine et Loire, France, 49100